Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-03

Clinical Trial Update: Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

The document reports a Phase 1 study evaluating LX3305 in combination with methotrexate for stable rheumatoid arthritis, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LX3305
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2010-06-03